Search

Search Constraints

You searched for: Author/Creator Kluth, Martina

Search Results

1. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer. Issue 10 (20th August 2018)

2. 5q21 deletion is often heterogeneous in prostate cancer. Issue 8 (24th January 2019)

3. Apurinic/apyrimidinic endonuclease 1 (APE1/Ref‐1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion. Issue 9 (22nd May 2017)

4. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. (January 2022)

5. Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer. Issue 3 (24th October 2020)

6. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer. Issue 6 (26th April 2014)

7. Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer. Issue 10 (4th June 2015)

8. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10, 439 tumors. Issue 2 (7th November 2022)

9. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer. Issue 3 (2nd November 2015)

10. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer. Issue 1 (December 2018)